Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

LogicBio Therapeutics, Inc. (LOGC) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2023 SC 13G/A Beryl Capital Management LLC reports a 0% stake in LogicBio Therapeutics, Inc.
02/10/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/29/2022 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
11/21/2022 EFFECT Form EFFECT - Notice of Effectiveness:
11/17/2022 4 Kay Mark A (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.
Txns: Disposed/sold 784,557 shares @ $0
Disposed/sold 140,615 options to buy @ $0.73, valued at $102.6k
Disposed/sold 13,089 options to buy @ $0.73, valued at $9.6k
Disposed/sold 12,500 options to buy @ $0.38, valued at $4.8k
11/17/2022 4 Enyedy Mark J (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.
Txns: Disposed/sold 2,921 shares @ $0
Disposed/sold 12,500 options to buy @ $0.38, valued at $4.8k
11/17/2022 4 Nacht Mariana (Chief Scientific Officer) has filed a Form 4 on LogicBio Therapeutics, Inc.
Txns: Disposed/sold 100,000 options to buy @ $0.7, valued at $70k
11/17/2022 4 WYZGA MICHAEL S (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.
Txns: Disposed/sold 3,141 shares @ $0
Disposed/sold 12,500 options to buy @ $0.38, valued at $4.8k
11/17/2022 4 Chereau Frederic (President, CEO) has filed a Form 4 on LogicBio Therapeutics, Inc.
Txns: Disposed/sold 253,811 shares @ $0
Disposed/sold 547,000 options to buy @ $0.73, valued at $399.3k
Disposed/sold 328,000 options to buy @ $0.7, valued at $229.6k
11/17/2022 4 MOSCICKI RICHARD A (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.
Txns: Disposed/sold 3,916 shares @ $0
Disposed/sold 12,500 options to buy @ $0.38, valued at $4.8k
11/17/2022 4 Goater Jeff (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.
Txns: Disposed/sold 12,500 options to buy @ $0.38, valued at $4.8k
11/17/2022 4 Karydas Daphne (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.
Txns: Disposed/sold 12,500 options to buy @ $0.38, valued at $4.8k
11/17/2022 4 Chen Leon (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.
Txns: Disposed/sold 22,333 shares @ $0
Disposed/sold 44,508 options to buy @ $0.73, valued at $32.5k
Disposed/sold 12,500 options to buy @ $0.38, valued at $4.8k
11/17/2022 4 Gruskin Daniel (Chief Medical Officer) has filed a Form 4 on LogicBio Therapeutics, Inc.
Txns: Disposed/sold 3,331 shares @ $0
Disposed/sold 140,000 options to buy @ $0.7, valued at $98k
11/17/2022 4 Kahn Susan (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.
Txns: Disposed/sold 12,500 options to buy @ $0.38, valued at $4.8k
11/16/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/16/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/16/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/16/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/16/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
11/16/2022 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "Fifth Amended and Restated Certificate of Incorporation of LogicBio Therapeutics, Inc",
"Amended and Restated Bylaws of LogicBio Therapeutics, Inc"
11/16/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
11/16/2022 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
11/16/2022 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/20/2022 8-K Quarterly results
10/20/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
10/18/2022 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
10/18/2022 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
10/13/2022 SC 13G Beryl Capital Management LLC reports a 9.9% stake in LogicBio Therapeutics, Inc.
10/07/2022 8-K Entry into a Material Definitive Agreement  Interactive Data
10/03/2022 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
10/03/2022 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
10/03/2022 8-K Quarterly results
09/30/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy